Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 4, 2005, Pages 557-559

  Fukumoto, Shinya ^a,b   Tamaki, Yoh ^a   Shirafuji, Hiroaki ^a   Harakawa, Shinji ^a,c   Suzuki, Hiroshi ^a   Xuan, Xuenan ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Hakujyu Institute for Health Science Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ANTIGEN; RECOMBINANT SURFACE ANTIGEN P50; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; HYBRID PROTEIN; MEMBRANE ANTIGEN; PARASITE ANTIGEN;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; BABESIA; BABESIA GIBSONI; DOG; DRUG EFFICACY; GROWTH INHIBITION; IMMUNIZATION; IMMUNOGENICITY; INFECTION CONTROL; INSECT CELL; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROTOZOAL INFECTION; ANIMAL; ANIMAL DISEASE; BABESIOSIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DOG DISEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INSECT; METABOLISM; METHODOLOGY; PARASITOLOGY; TIME; WESTERN BLOTTING;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; BABESIA; BABESIOSIS; BLOTTING, WESTERN; CELLS, CULTURED; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; INSECTS; RECOMBINANT FUSION PROTEINS; TIME FACTORS;

EID: 22844438324     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.4.557-559.2005     Document Type: Article

References (16)

1. Brown, W. C., and G. H. Palmer. 1999. Designing blood-stage vaccines against Babesia bovis and B. bigemina. Parasitol. Today 15:275-281.
2. Casapulla, R., L. Baldi, V. Avallone, R. Sannino, L. Pazzanese, and V. Mizzoni. 1998. Canine piroplasmosis due to Babesia gibsoni: clinical and morphological aspects. Vet. Rec. 142:168-169.
3. Chang, Y.-F., M. J. G. Appel, R. H. Jacobson, S. J. Shin, P. Harpending, R. Straubinger, L. A. Patrican, H. Mohammed, and B. A. Summers. 1995. Recombinant OspA protects dogs against infection and disease caused by Botrelia burgdorfen. Infect. Immun. 63:3543-3549.
4. Fukumoto, S., Y. Sekine, X. Xuan, I. Igarashi, C. Sugimoto, H. Nagasawa, K. Fujisaki, T. Mikami, and H. Suzuki. 2004. Serodiagnosis of canine Babesia gibsoni infection by enzyme-linked immunosorbent assay with recombinant P50 expressed in Escherichia coli. J. Parasitol. 90:387-391.
5. Fukumoto, S., X. Xuan, N. Takabatake, I. Igarashi, C. Sugimoto, K. Fujisaki, H. Nagasawa, T. Mikami, and H. Suzuki. 2004. Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells. Infect. Immun. 72:1795-1798.
6. Fukumoto, S., X. Xuan, K. Kadota, I. Igarashi, C. Sugimoto, K. Fujisaki, H. Nagasawa, T. Mikami, and H. Suzuki. 2003. High-level expression of truncated surface antigen P50 of Babesia gibsoni in insect cells by baculovirus and evaluation of its immunogenicity and antigenicity. Clin. Diagn. Lab. Immunol. 10:596-601.
7. Fukumoto, S., X. Xuan, Y. Nishikawa, N. Inoue, I. Igarashi, H. Nagasawa, K. Fujisaki, and T. Mikami. 2001. Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 39:2603-2609.
8. Ishimine, T., S. Makimura, S. Kitazawa, S. Tamura, and N. Suzuki. 1978. Pathophysiological findings on blood of Beagles experimentally infected with Babesia gibsoni. Jpn. J. Trop. Med. Hyg. 6:15-26.
9. Jenkins, M. C. 2001. Advances and prospects for subunit vaccines against protozoa of veterinary importance. Vet. Parasitol. 101:291-310.
10. + T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect. Immun. 69:681-686.
11. Schetters, T. P., J. Kleuskens, N. Scholtes, and H. J. Bos. 1992. Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture. Parasite Immunol. 14:295-305.
12. Schneider, J., S. C. Gilbert, T. J. Blanchard, T. Hanke, K. J. Robson, C. M. Hannan, M. Becker, R. Sinden, G. L. Smith, and A. V. Hill. 1998. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397-402.
13. Schneider, J., S. C. Gilbert, C. M. Hannan, P. Degano, E. Prieur, E. G. Sheu, M. Plebanski, and A. V. Hill. 1999. Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170:29-38.
14. Sullivan, N. J., A. Sanchez, P. E. Rollin, Z. Y. Yang, and G. J. Nabel. 2000. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408:605-609.
15. Wozniak, E. J., B. C. Barr, J. W. Thomford, I. Yamane, S. P. McDonough, P. F. Moore, D. Naydan, T. W. Robinson, and P. A. Conrad. 1997. Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris). J. Parasitol. 83:692-699.
16. Yamane, I., P. A. Conrad, and I. Gardner. 1993. Babesia gibsoni infections in dogs. J. Protozool. Res. 3:111-125.